Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance

26th January 2026 Uncategorised 0

With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug conjugates. But the road to market leadership is growing more complex as the two AstraZeneca-partnered brands move into earlier lines of therapy while facing intensifying competition.

More: Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance
Source: fierce